Title: Batimastat
CAS Registry Number: 130370-60-4
CAS Name: (2
R,3
S)-
N4-Hydroxy-
N1-[(1
S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]butanediamide
Synonyms: (2
S,3
R)-5-methyl-3-[[(a
S)-a-(methylcarbamoyl)phenethyl]carbamoyl]-2-[(2-thienylthio)methyl]hexanohydroxamic acid; [4-(
N-hydroxyamino)-2
R-isobutyl-3
S-(2-thienylthiomethyl)succinyl]-L-phenylalanine-
N-methylamide
Manufacturers' Codes: BB-94
Molecular Formula: C23H31N3O4S2
Molecular Weight: 477.64
Percent Composition: C 57.84%, H 6.54%, N 8.80%, O 13.40%, S 13.43%
Literature References: Synthetic matrix metalloproteinase inhibitor. Prepn: C. Campion
et al., WO 9005719;
eidem, US 5240958 (1990, 1993 both to British Biotech.). Effect on transplanted human ovarian carcinoma: B. Davies
et al., Cancer Res. 53, 2087 (1993). Inhibition of metastasis of transplanted human colorectal carcinoma: X. Wang
et al., ibid. 54, 4726 (1994).
Properties: Fine white powder. mp 236-238°.
Melting point: mp 236-238°
Therap-Cat: Antineoplastic adjunct (antimetastatic agent).
Keywords: Antineoplastic Adjunct; Antimetastatic Agent; Matrix Metalloproteinase Inhibitor.